Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
about
Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?Pathophysiological mechanisms of death resistance in colorectal carcinomaBiomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory scienceCancer prevention as part of precision medicine: 'plenty to be done'Epidemiology of colorectal cancerChemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisAlleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsMolecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.Genetic architecture of colorectal cancer.The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.Population-wide Impact of Long-term Use of Aspirin and the Risk for CancerCancer Prevention: Obstacles, Challenges and the Road Ahead.Transforming Cancer Prevention through Precision Medicine and Immune-oncology.Leveraging premalignant biology for immune-based cancer prevention.Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.Drug repurposing in oncology--patient and health systems opportunities.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Chemoprevention of colorectal neoplasia.Aspirin and colorectal cancer: the promise of precision chemoprevention.Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.The role of aspirin in preventing colorectal cancer.The potential role of platelets in the consensus molecular subtypes of colorectal cancer.Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma.Association between colorectal polyps and hypertension treatment.Aspirin use and the risk of cholangiocarcinoma.The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.Incidence of cancers in patients with atherosclerotic cardiovascular diseasesTherapeutic strategies against cancer stem cells in human colorectal cancer.Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.A novel SNP in promoter region of RP11-3N2.1 is associated with reduced risk of colorectal cancer.Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?Colorectal Cancers: An Update on Their Molecular Pathology.
P2860
Q26749127-089DD9A5-26B5-434E-BA31-F7CCB08C4EFFQ26778007-E3C6470B-A333-49DB-83E1-DD03C72DE31AQ26778374-135EECAD-3645-44B7-86FB-6FFEB95B3FF1Q26995183-370F29A7-D8ED-48BB-94C7-36ABADA3816DQ28067871-94285D8E-B4CD-4511-9F45-CB4CD2951EAAQ28589784-12345940-80D0-42C3-9335-E5336F1E0D48Q30234292-6663CFD9-2741-449E-99F0-182E06D927B2Q30244608-D94C7E18-B621-45BF-855A-5AD9AE502780Q30251624-FE1C12E8-0C0A-4D9A-9394-606251816A8FQ33728638-36154F35-CCC5-4AC6-B9F6-64302FA84C33Q36053127-531B1B9F-1F08-4CAA-B05B-D6577A2675A0Q36261529-B7E92661-0F02-48FA-A5C9-0080D07A6EB3Q36989392-EB43FB1A-DC6A-41C8-B081-BE1299FE3DB8Q37002946-36D0B025-667E-4FC1-AFD9-55745235C782Q37114360-DB91AC26-E44B-48F8-BE61-E3E1F1D17E90Q37304964-2CEFBA3B-A5D3-4A58-84D8-1F5223C46432Q37413259-925559F6-8817-4113-A7AD-F6E2BD77B3D3Q38549743-3CE42956-DC4F-4602-91F7-6007977696DCQ38571347-9CDA3A22-1E68-4769-AC3B-CF685DB251FBQ38611707-0DFAD90E-042A-47C4-81DB-430295F624F9Q38668187-3199B5B3-BC89-441D-B5B9-A000DF2A0069Q38674336-CDCD5741-2DF6-4D90-961C-6EC3760F3B14Q38730064-1D461CF4-00A9-4BFA-A835-DB34CA1F45F1Q38850128-E9796EF8-AF6A-4057-B03C-2A02FF82CD8CQ38932550-669EE48C-FEC2-4829-840D-9BC26C8716E8Q39417307-49A64B12-CD6C-4273-A680-3896348395FDQ39530717-B291D6C3-E556-4CDE-B83E-4D90195C7820Q39947451-6FFF20CB-1949-4F2A-A78C-E75F54F7EC71Q40352933-644059F0-926B-44CF-9792-15E8C0731AE6Q40503483-5C1A1EA5-B3A7-49C3-9110-0BCC1CF5AE85Q40554318-73AAAEFA-DB8A-406D-B0B9-8C2E99B6A30DQ40873283-222B47C2-D26B-423B-9478-C88DC7DAB205Q41093379-89ADCBA4-C9EB-4F33-8FD6-E2409081B975Q41692410-20D21461-F9B3-4FEB-BA3D-76ADC9FB5B29Q47149854-DC5B3F7D-770B-4F93-A440-C9DECC573C2EQ47171553-5E51E73E-E5A4-48D9-B4B6-53BA5554F253Q47321577-0B1A870E-A280-4261-86D7-22BA9B4C52C4Q47426131-22611269-6728-4ED5-A467-A340F1794C4AQ47817255-1BBE825F-A455-419E-ADD5-BC809666C95CQ48182864-44E01C4E-6010-40C8-9550-3CADD56A316D
P2860
Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Association of aspirin and NSA ...... according to genetic variants.
@ast
Association of aspirin and NSA ...... according to genetic variants.
@en
type
label
Association of aspirin and NSA ...... according to genetic variants.
@ast
Association of aspirin and NSA ...... according to genetic variants.
@en
prefLabel
Association of aspirin and NSA ...... according to genetic variants.
@ast
Association of aspirin and NSA ...... according to genetic variants.
@en
P2093
P2860
P50
P356
P1476
Association of aspirin and NSA ...... according to genetic variants.
@en
P2093
Andrew T Chan
Bethann M Pflugeisen
Brent W Zanke
Carolyn M Hutter
Christopher S Carlson
Conghui Qu
Cornelia M Ulrich
David Duggan
Emily White
P2860
P304
P356
10.1001/JAMA.2015.1815
P407
P50
P577
2015-03-01T00:00:00Z